Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raptiva versus placebo for hand and/or foot plaque psoriasis
2007-004227-37Phase 4Terminated
- Sponsor
- Merck Serono
- Start
- Nov 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in plaque psoriasis and palmoplantar psoriasis comparing Raptiva with Placebo (2 arms). Primary endpoint: Week 12 PGA-H&F response. Started Nov 2007; status: terminated.
02
Drugs
efalizumab
03
Conditions
plaque psoriasispalmoplantar psoriasis
Beyond the preview
Go deeper on 2007-004227-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004227-37.